CGON Earnings & Financial Statements
CG Oncology, Inc. Common stock
$62.75
+$0.91(+1.47%)
40
Overall
55
Value
20
Tech
47
Quality
Market Cap
$5.48B
Volume
62.05K
52W Range
$35.80 - $80.97
Target Price
$90.64
CGON earnings and financial statements: CG Oncology, Inc. Common stock's income statement, balance sheet and cash flow statement, annual and quarterly.
CGON Annual Financial Statements
| Fiscal year | 2025 | 2024 |
|---|---|---|
| Revenue | $4.04M | $1.14M |
| Cost of revenue | $4.65M | - |
| Operating income | -$190.77M | -$114.67M |
| EBITDA | -$159.55M | -$88.01M |
| Net income | -$161.00M | -$88.04M |
| EPS (diluted) | $-2.08 | $-1.41 |
| Fiscal year | 2025 | 2024 |
|---|---|---|
| Total assets | $791.59M | $754.80M |
| Total liabilities | $38.99M | $21.42M |
| Shareholders’ equity | $752.60M | $733.38M |
| Cash and equivalents | $32.49M | $257.07M |
| Long-term debt | $6.11M | $52.0K |
| Fiscal year | 2025 | 2024 |
|---|---|---|
| Operating cash flow | -$132.30M | -$78.71M |
| Capital expenditure | -$134.0K | -$234.0K |
| Free cash flow | -$132.43M | -$78.95M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | CGON | $62.75 | +1.5% | 62.05K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get CG Oncology, Inc. Common stock Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW